Fresenius Medical Care AG (NYSE:FMS)‘s stock had its “buy” rating reissued by research analysts at Goldman Sachs Group Inc. in a report issued on Wednesday.

FMS has been the topic of a number of other research reports. DZ Bank AG reissued a “neutral” rating on shares of Fresenius Medical Care AG in a research note on Friday, September 16th. Citigroup Inc. upgraded Fresenius Medical Care AG from a “neutral” rating to a “buy” rating in a research report on Tuesday, September 6th. Jefferies Group upgraded Fresenius Medical Care AG from an “underperform” rating to a “hold” rating in a research report on Friday, July 8th. Royal Bank Of Canada restated a “hold” rating on shares of Fresenius Medical Care AG in a research report on Tuesday, May 24th. Finally, Berenberg Bank restated a “buy” rating on shares of Fresenius Medical Care AG in a research report on Tuesday, August 9th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and seven have issued a buy rating to the stock. Fresenius Medical Care AG currently has a consensus rating of “Hold” and a consensus target price of $42.50.

Analyst Recommendations for Fresenius Medical Care AG (NYSE:FMS)

Shares of Fresenius Medical Care AG (NYSE:FMS) opened at 44.03 on Wednesday. Fresenius Medical Care AG has a 12 month low of $38.11 and a 12 month high of $47.52. The company’s 50-day moving average price is $45.27 and its 200-day moving average price is $43.75. The company has a market cap of $26.92 billion, a P/E ratio of 24.41 and a beta of 0.53.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/fresenius-medical-care-ag-fms-rating-reiterated-by-goldman-sachs-group-inc.html

Fresenius Medical Care AG (NYSE:FMS) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $0.96 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.92 by $0.04. The company had revenue of $4.42 billion for the quarter, compared to analyst estimates of $4.54 billion. Fresenius Medical Care AG had a return on equity of 9.66% and a net margin of 6.40%. Equities analysts forecast that Fresenius Medical Care AG will post $2.01 EPS for the current fiscal year.

Several large investors have recently bought and sold shares of FMS. Sterling Capital Management LLC purchased a new stake in Fresenius Medical Care AG during the second quarter valued at about $235,000. Stifel Financial Corp increased its stake in shares of Fresenius Medical Care AG by 56.5% in the second quarter. Stifel Financial Corp now owns 12,344 shares of the company’s stock valued at $539,000 after buying an additional 4,456 shares during the period. FDx Advisors Inc. increased its stake in shares of Fresenius Medical Care AG by 0.9% in the second quarter. FDx Advisors Inc. now owns 5,597 shares of the company’s stock valued at $244,000 after buying an additional 51 shares during the period. A.R.T. Advisors LLC bought a new stake in shares of Fresenius Medical Care AG during the second quarter valued at $599,000. Finally, Eagle Global Advisors LLC increased its stake in shares of Fresenius Medical Care AG by 3.9% in the second quarter. Eagle Global Advisors LLC now owns 66,100 shares of the company’s stock valued at $2,880,000 after buying an additional 2,500 shares during the period. Hedge funds and other institutional investors own 2.33% of the company’s stock.

Fresenius Medical Care AG Company Profile

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

5 Day Chart for NYSE:FMS

Receive News & Ratings for Fresenius Medical Care AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG and related companies with MarketBeat.com's FREE daily email newsletter.